Yoshihiko Soga

Dr. Yoshihiko Soga

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
THTomoko Higuchi
Tomoko Higuchi
YSYoshihiko Soga
Yoshihiko Soga
MMMisato Muro
Misato Muro
MKMakoto Kajizono
Makoto Kajizono
YKYoshihisa KITAMURA
Yoshihisa KITAMURA
ASAkira Sasaki
Akira Sasaki

1 August 2007 in Innate Immunity
Verified
Journal Article
Closed access
HIHirotaka Iwata
Hirotaka Iwata
YSYoshihiko Soga
Yoshihiko Soga
MMMichio Meguro
Michio Meguro
SYSayuri Yoshizawa
Sayuri Yoshizawa
YOYuka Okada
Yuka Okada
FNFusanori Nishimura
Fusanori Nishimura
Diabetic subjects are susceptible to atherosclerosis. It has been postulated that inflammation plays a crucial role in atherogenesis. Since previous studies suggested persistent low-grade infection by Gram-negative bacteria such as Chlamydia spp. and/or periodontal infection is associated with increased atherogenesis among diabetic subjects, we hypothesized that macrophages under hyperglycemia respond to lipopolysaccharide (LPS) challenge in a more exaggerated manner than under normal glucose conditions. Therefore, we examined cytokine productivity and associated signal transduction molecules in LPS-stimulated the monocytic cell line THP-1, under conditions of hyperglycemia. Differentiated THP-1 cells were cultured under normal and high glucose conditions without fetal bovine serum, and were stimulated with Escherichia coli LPS in the presence of LPS binding protein. Following stimulation, activated signal transduction molecules were detected by protein microarray and confirmed thereafter. Results indicated that c-jun N-terminal kinase (JNK) was highly-phosphorylated at high glucose concentrations, and this was confirmed by Western-immunoblotting. Tumor necrosis factor-α and monocyte chemo-attractant protein-1 production were significantly enhanced under these conditions. SP600125, a selective inhibitor of JNK, dose-dependently suppressed the production of these cytokine. Therefore, we suggest that this may be one of the mechanisms by which sub-clinical infection by Gram-negative bacteria promotes atherosclerosis in diabetic subjects.

20 February 2025 in Blood
Verified
Journal Article
Open access
YKYui Kambara
Yui Kambara
HFHideaki Fujiwara
Hideaki Fujiwara
AYAkira Yamamoto
Akira Yamamoto
KGKazuyoshi Gotoh
Kazuyoshi Gotoh
STShuma Tsuji
Shuma Tsuji
YMYoshinobu Maeda
Yoshinobu Maeda
The oral microbiota, second in abundance to the gut, is implicated in chronic systemic diseases, but its specific role in graft-versus-host disease (GVHD) pathogenesis has been unclear. Our study finds that mucositis-induced oral dysbiosis in patients after hematopoietic cell transplantation (HCT) associated with increased chronic GVHD (cGVHD), even in patients receiving posttransplant cyclophosphamide. In murine HCT models, oral dysbiosis caused by bilateral molar ligatures exacerbated cGVHD and increased bacterial load in the oral cavity and gut, with Enterococcaceae significantly increasing in both organs. In this model, the migration of Enterococcaceae to cervical lymph nodes both before and after transplantation activated antigen-presenting cells, thereby promoting the expansion of donor-derived inflammatory T cells. Based on these results, we hypothesize that pathogenic bacteria increase in the oral cavity might not only exacerbate local inflammation but also enhance systemic inflammation throughout the HCT course. Additionally, these bacteria translocated to the gut and formed ectopic colonies, further amplifying systemic inflammation. Furthermore, interventions targeting the oral microbiome mitigated murine cGVHD. Collectively, our findings highlight the importance of oral dysbiosis in cGVHD and suggest that modulation of the oral microbiome during transplantation may be an effective approach for preventing or treating cGVHD.

12 March 2018 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
MMMisato Muro
Misato Muro
YSYoshihiko Soga
Yoshihiko Soga
THTomoko Higuchi
Tomoko Higuchi
KKKota Kataoka
Kota Kataoka
DEDaisuke Ekuni
Daisuke Ekuni
MMManabu Morita
Manabu Morita

1 March 2005 in Journal of Dental Research
Verified
Journal Article
Closed access
PDF file
MYM. Yamaguchi
M. Yamaguchi
FNF. Nishimura
F. Nishimura
HNH. Naruishi
H. Naruishi
YSYoshihiko Soga
Yoshihiko Soga
SKS. Kokeguchi
S. Kokeguchi
STShogo Takashiba
Shogo Takashiba
An elevated level of C-reactive protein (CRP) predicts the future development of coronary heart disease. Periodontitis appears to up-regulate CRP. CRP is produced by hepatocytes in response to interleukin-6 (IL-6). A major source of IL-6 in obese subjects is adipocytes. We hypothesized that lipopolysaccharide (LPS) from periodontal pathogens stimulated adipocytes to produce IL-6, and that the production was suppressed by the drugs targeted against insulin resistance, thiazolidinedione (pioglitazone), since this agent potentially showed an anti-inflammatory effect. Mouse 3T3-L1 adipocytes were stimulated with E. coli, P. gingivalis, and F. nucleatum LPS. The IL-6 concentration in culture supernatants was measured. All LPS stimulated adipocytes to produce IL-6. Although pioglitazone changed adipocyte appearance from large to small, and completely suppressed P. gingivalis and F. nucleatum LPS-induced IL-6 production, E. coli LPS-induced IL-6 production was not efficiently blocked. Thus, pioglitazone completely blocked periodontal-bacteria-derived LPS-induced IL-6 production in adipocytes, a major inducer of CRP.

21 May 2016 in Gerodontology
Verified
Journal Article
Closed access
PDF file
NKNaoki Kobayashi
Naoki Kobayashi
YSYoshihiko Soga
Yoshihiko Soga
KMKyoko Maekawa
Kyoko Maekawa
YKYuko Kanda
Yuko Kanda
EKEiko Kobayashi
Eiko Kobayashi
YFYumi Fujiwara
Yumi Fujiwara